CardioGenesis Announces Initial Public Offering of Common Stock.SUNNYVALE, Calif.--(BUSINESS WIRE)--May 22, 1996--CardioGenesis Corp., (the "Company") (NASDAQ NASDAQ in full National Association of Securities Dealers Automated Quotations U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on : CGCP) announced today the initial public offering of 3,000,000 shares of common stock at a price of $20 per share. All 3,000,000 shares were offered by the Company. Following the offering, the Company has approximately 11,928,000 shares of common stock outstanding. The Company has granted the underwriters a 30-day option to purchase up to an additional 450,000 shares of common stock to cover over-allotments, if any. The offering was made through an underwriting group managed by Bear, Stearns & Co. Inc., Montgomery Securities and Piper Jaffray Inc. The Company is developing proprietary methods and systems, including disposable components, to perform both surgical transmyocardial revascularization ("TMR TMR total mixed ration. TMR 1 Trainable mentally retarded 2 Transmyocardial revascularization, see there ") and catheter-based percutaneous myocardial revascularization percutaneous myocardial revascularization Percutaneous transluminal myocardial revascularization, see there . TMR is used to treat patients with severe coronary artery disease coronary artery disease, condition that results when the coronary arteries are narrowed or occluded, most commonly by atherosclerotic deposits of fibrous and fatty tissue. who suffer from recurrent debilitating de·bil·i·tat·ing adj. Causing a loss of strength or energy. Debilitating Weakening, or reducing the strength of. Mentioned in: Stress Reduction chest pain. A copy of the prospectus relating to the offering may be obtained from Bear, Stearns & Co. Inc., 245 Park Avenue, New York, N.Y. 10167, 212/272-2000; Montgomery Securities, 600 Montgomery Street, San Francisco, Calif., 94111, 415/627-2000; or Piper Jaffray Inc., 222 South Ninth Street, Minneapolis, Minn. 55402, 612/342-6000. CONTACT: CardioGenesis Corp., Sunnyvale Richard P. Powers, 408/328-8500 |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion